Stock Events

Stock Events

BB Biotech 

$76.06
293
+$0.00+0%Monday 21:00

Statistics

Day High
33.65
Day Low
33.65
52W High
76.06
52W Low
33.65
Volume
100
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
3.58%
Dividend
2.73

Upcoming

Dividends

3.58%Dividend Yield
Mar 2026
$2.84
Mar 2025
$2.04
Mar 2024
$2.21
Mar 2023
$3.10
Mar 2022
$4.14
10Y Growth
19.54%
5Y Growth
-5.46%
3Y Growth
-4.94%
1Y Growth
30.1%

Earnings

Jan 22Expected
Q2 2020
Q3 2020
Q3 2024
Q1 2026
Q2 2026
Q3 2026
Next
-6.64
2.27
11.17
20.07
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BBAGF. It's not an investment recommendation.
Microsoft
31
MSFT
Nestle SA
30
NESN.SW
Apple
28
AAPL
Bayer
27
BAYN.XETRA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
iShares Biotechnology
IBB
Mkt Cap0
iShares Biotechnology ETF, competes by investing in biotech companies, similar to BB Biotech's investment strategy.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, competes as it also focuses on biotechnology investments, offering a similar market exposure.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund, a direct competitor through its biotech-focused investment portfolio.
ARK Genomic Revolution
ARKG
Mkt Cap0
ARK Genomic Revolution ETF, competes by investing in the genomic industry, overlapping with BB Biotech's investment interests.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, offers exposure to biotech firms, directly competing with BB Biotech's investment focus.
Principal Healthcare Innovators Index
BTEC
Mkt Cap0
Principal Healthcare Innovators Index ETF, competes by focusing on healthcare innovation, including biotech, similar to BB Biotech.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF, competes through its focus on biotech and genomic revolution, akin to BB Biotech's strategy.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF, competes by investing in small- and mid-cap biotech companies, a market segment also targeted by BB Biotech.
Direxion Daily S&P Biotech Bull 3X
LABU
Mkt Cap0
Direxion Daily S&P Biotech Bull 3X Shares, competes as a leveraged ETF focusing on biotech, offering aggressive exposure similar to BB Biotech's sector focus.
Direxion Daily S&P Biotech Bear 3X
LABD
Mkt Cap0
Direxion Daily S&P Biotech Bear 3X Shares, competes by offering inverse exposure to the biotech sector, providing an alternative strategy to BB Biotech's investments.

About

BB Biotech AG functions as an equity investment vehicle, managed by Bellevue Asset Management AG. Its investment mandate extends to publicly traded companies across the globe, with a particular focus on firms engaged in modern biotechnology for medications and diagnostic tools. The construction of its portfolio is driven by a rigorous fundamental analysis. This Swiss-domiciled entity was established on November 9, 1993.
Show More
CEO
Daniel Koller
Employees
10
Country
Switzerland
ISIN
CH0038389992
WKN
000A0NFN3

Listings

F
DE
BBZA.F
LSE
GB
0JYO.LSE
MU
DE
BBZA.MU
SW
CH
BION.SW

0 Comments

Share your thoughts

FAQs

What is BB Biotech stock price today?▼
The current price of BBAGF is $76.06 USD — it has increased by +0% in the past 24 hours. Watch BB Biotech stock price performance more closely on the chart.
What is BB Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BB Biotech stocks are traded under the ticker BBAGF.
When is the next BB Biotech earnings date?▼
BB Biotech is going to release the next earnings report on January 22, 2027.
Does BB Biotech pay dividends?▼
Yes, BBAGF dividends are paid annual. The last dividend per share was 2.84 . As of today, Dividend Yield (FWD)% is 3.58%.
How many employees does BB Biotech have?▼
As of November 12, 2026, the company has 10 employees.
In which sector is BB Biotech located?▼
BB Biotech operates in the Finance & Payments sector.
When did BB Biotech complete a stock split?▼
The last stock split for BB Biotech was on March 29, 2016 with a ratio of 5:1.
Where is BB Biotech headquartered?▼
BB Biotech is headquartered in Kusnacht, Switzerland.